Stock PV3B EYEPOINT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart EyePoint Pharmaceuticals, Inc. Deutsche Boerse AG

Equities

PV3B

US30233G2093

Real-time Estimate Tradegate
Other stock markets
 01:33:43 2024-06-17 pm EDT 		5-day change 1st Jan Change
8.426 EUR -1.10% Intraday chart for EyePoint Pharmaceuticals, Inc. +3.53% -59.57%
Jun. 12 Transcript : EyePoint Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 03:20 PM
Jun. 04 JPMorgan Adjusts EyePoint Pharmaceuticals Price Target to $32 From $35, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EYEPOINT PHARMACEUTICALS, INC.
Other Pharmaceuticals
+0.61%+3.53%-59.57%+45.29%-35.93% 489M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. EYPT Stock
  4. PV3B Stock
  5. Charts EyePoint Pharmaceuticals, Inc.
  6. Comparison Chart